(Q59624941)
Statements
Interruption of antiretroviral therapy initiated during primary HIV-1 infection: impact of a therapeutic vaccination strategy combined with interleukin (IL)-2 compared with IL-2 alone in the ANRS 095 Randomized Study (English)
Houria Hendel-Chavez
Marianne Burgard
Vincent Meiffrédy
Alain Venet
Yacine Taoufik
Raphaëlle El Habib
Maria Beumont-Mauviel
Jean-Pierre Aboulker
Yves Lévy
Jean-François Delfraissy
Christine Rouzioux
PRIMOVAC-ANRS 095 Study Group
1 September 2007